YD BioMed expects to advance two lead ophthalmology programs utilizing its LSC Exosome platform, each supported by targeted regulatory and clinical milestones, which the timing of these milestones ...

Authorized Distributor Since 2003 Reports Biocide-Free Clear Choice Products See Increased Q1 Demand as Medical Cannabis Users Face Employment Testing in 38 States Without Workplace Protections ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

After years pushing for regime change, the US secretary of state is now tasked with helping run a fractured country of 29 ...

This study presents SynaptoGen, a differentiable extension of connectome models that links gene expression, protein-protein interaction probabilities, synaptic multiplicity, and synaptic weights, and ...

Sujit Murumkar is a visionary leader who designed and implemented enterprise scale modern data ecosystems for one of the ...

A few 2025 trials pointed in the same direction: toward treatments built to modify disease biology and better ways to measure ...

ADHD medications work like sleep, not attention boosters, massive brain study reveals. For some kids, focus problems may be ...

There are no established treatment options for patients with meningioma recurring after surgery and radiotherapy.

Detailed price information for GT Biopharma Inc (GTBP-Q) from The Globe and Mail including charting and trades.

Introduction Application of artificial intelligence (AI) tools in the healthcare setting gains importance especially in the domain of disease diagnosis. Numerous studies have tried to explore AI in ...

Get an inside look at the life of Nurse Blake. He discusses his challenges as a gay man, triumphs, and advocacy in the ...